Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters 6 months [clinicaltrials_resource:6ea740de590820501ea1575859c9027a]
SynergEyes A2 is a hybrid contact lens cleared by the US Food and Drug Administration (FDA) for daily wear correction of up to +20.00 and -20.00 in eyes with astigmatism up to 6.00D and for presbyopia.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters 6 months [clinicaltrials_resource:6ea740de590820501ea1575859c9027a]
SynergEyes A2 is a hybrid contact lens cleared by the US Food and Drug Administration (FDA) for daily wear correction of up to +20.00 and -20.00 in eyes with astigmatism up to 6.00D and for presbyopia.
Bio2RDF identifier
6ea740de590820501ea1575859c9027a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6ea740de590820501ea1575859c9027a
measure [clinicaltrials_vocabulary:measure]
Confirm current SynergEyes A2 ...... tive and subjective parameters
time frame [clinicaltrials_vocabulary:time-frame]
description
SynergEyes A2 is a hybrid cont ...... p to 6.00D and for presbyopia.
identifier
clinicaltrials_resource:6ea740de590820501ea1575859c9027a
title
Confirm current SynergEyes A2 ...... subjective parameters 6 months
@en
type
label
Confirm current SynergEyes A2 ...... 740de590820501ea1575859c9027a]
@en